This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

George Rosenkranz To Receive 2013 Biotechnology Heritage Award

Award presented during keynote lunch at the 2013 BIO International Convention.

CHICAGO and PHILADELPHIA, April 21, 2013 /PRNewswire-USNewswire/ -- The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) have selected George Rosenkranz as the winner of the 2013 Biotechnology Heritage Award. The award will be presented during a keynote lunch on Tuesday, April 23, at BIO's  annual international convention, which begins tomorrow in Chicago.

" George Rosenkranz has pioneered with brilliance in steroid chemistry; innovated with legendary success in the pharmaceutical industry; and recruited, mentored, and guided individuals of great talent to stellar careers. He unites in his person European charm, Hispanic courtesy, and American entrepreneurial spirit," says James C. Greenwood, President and CEO of BIO. "George led the development of the oral contraceptive pill, served as chairman of the corporation that brought it to the global market, and thereby permanently changed world culture."

About George Rosenkranz



George Rosenkranz joined Syntex Corporation in 1945 and retired as CEO and board chairman in 1981. During his years with Syntex, Rosenkranz created and guided an academic research group of star-studded brilliance, which included Alex Zaffaroni and Carl Djerassi, first as his junior collaborators, then as his lifelong friends. Revolutionary advances in the intellectual understanding of and production techniques for steroid drugs were developed under Rosenkranz's direction, using native Mexican plant sources as raw materials. Syntex became the leading supplier of the oral contraceptive pill and other corticoids.

Rosenkranz's accomplishments have encompassed every aspect of the steroid hormone industry. He holds over 150 patents and has published more than 300 research articles on steroid hormones.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,214.42 -10.15 -0.06%
S&P 500 2,110.74 -3.12 -0.15%
NASDAQ 4,987.89 +20.7530 0.42%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs